Table 2 Demographics, clinical and obstetric characteristics (n = 27)
Characteristics | N |
|---|---|
Country of birth | |
Australia | 18 |
Other (India, Philippines, Nigeria, Malaysia, Indonesia, United Kingdom) | 9 |
Other health conditions | |
None | 16 |
Kidney disease | 4 |
Depression | 3 |
Type 2 diabetes | 1 |
Congenital heart disease | 1 |
Carpal tunnel syndrome | 1 |
Rheumatoid arthritis | 1 |
Gestational stage at interview | |
Second trimester | 6 |
Third trimester (32–34 weeks) | 5 |
Third trimester (35–37 weeks) | 6 |
Third trimester (≥37 weeks) | 9 |
1 day postpartum | 1 |
Time of hypertension diagnosis | |
Pre-pregnancy | 18 |
Current antihypertensive regimen started during pregnancy | 9 |
< 20 weeks | 3 |
At 20 weeks | 0 |
> 20 weeks | 6 |
Subtype of hypertensiona | |
Gestational hypertension | 3 |
Pre-eclampsia | 3 |
Severe pre-eclampsia | 2 |
Chronic hypertension | 10 |
Secondary hypertension | 3 |
Pre-eclampsia superimposed on chronic hypertension | 4 |
Severe pre-eclampsia superimposed on chronic hypertension | 1 |
Pre-eclampsia superimposed on secondary hypertension | 1 |
Severity of hypertensive diseasea | |
Mild-moderate | 20 |
Severe | 7 |
Antihypertensive medicationb | |
Methyldopa | 11 |
Labetalol | 15 |
Atenolol | 2 |
Nifedipine | 1 |
Oxprenolol | 1 |
Phenoxybenzamine | 1 |